Genome Res. 13:1696-1705, 2003
©2003 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/03 $5.00
Letter
Identification of a Large Novel Imprinted Gene Cluster on Mouse Proximal Chromosome 6
Ryuichi Ono, Research Fellow1,2,3,
Hirosuke Shiura1,
Hiroyuki Aburatani4,
Takashi Kohda1,3,
Tomoko Kaneko-Ishino3,5 and
Fumitoshi Ishino1,3,6
1 Gene Research Center, Tokyo Institute of Technology, Yokohama 226-8501,
Japan
2 Japan Society for the Promotion of Science, Tokyo 102-8471,
Japan
3 CREST, Japan Science and Technology Corporation (JST), Saitama 332-0012,
Japan
4 Genome Science Division, Research Center for Advanced Science and
Technology, The University of Tokyo, Tokyo 153-8904, Japan
5 Tokai University, School of Health Sciences, Kanagawa 259-1193,
Japan
 |
ABSTRACT
|
|---|
Mice with maternal duplication of proximal chromosome 6 die in utero at an
early embryonic stage. Recently, two imprinted genes, paternally expressed
Sgce and maternally expressed Asb4, were identified in this
region. This report analyzes the imprinting status of genes within a 1-Mb
region containing these two genes. Peg10, which is next to
Sgce, shows complete paternal expression, like Sgce.
Conversely, Neurabin, Pon2, and Pon3 show preferential maternal
expression at embryonic stages, although they all show biallelic expression in
neonatal tissues. These results demonstrate that there is a large novel
imprinted gene cluster in this region. 5'-RACE (Rapid Amplification of
cDNA Ends) analysis of Peg10 revealed the existence of a novel first
exon separate from the second exon, which encoded two putative ORFs similar to
the viral Gag and Pol proteins. A differentially methylated region established
in sperm and eggs is located just within the region containing the two first
exons of Peg10 and Sgce, and may play an important role in
regulating the two paternally expressed genes: Peg10 and
Sgce.
Maternal uniparental duplication in mouse proximal chromosome 6 causes
early embryonic lethality (Beechey
2000 ; also see
http://www.mgu.har.mrc.ac.uk/imprinting/imprinting.html ).
Previously, we identified Peg1/Mest as the first imprinted gene in
the mouse proximal chromosome 6
(Kaneko-Ishino et al. 1995 ).
However, Peg1/Mest-deficient mice show perinatal growth retardation
and abnormal maternal behavior, but do not show early embryonic lethality
(Lefebvre et al. 1998 ).
Recently, the existence of two imprinted regions has been demonstrated in this
region; mice with a maternal duplication proximal to T77H die in utero before
11.5 dpc, whereas those with a duplication distal to T77H show growth
retardation (Beechey 2000 ).
Peg1/Mest maps to the latter region, and two novel imprinted genes,
paternally expressed Sgce and maternally expressed Asb4,
have been identified in the former region
(Piras et al. 2000 ;
Mizuno et al. 2002 ). We have
also reported that human retrotransposon-derived PEG10, which is
adjacent to SGCE, is a paternally expressed imprinted gene
(Ono et al. 2001 ).
Because many imprinted genes form clusters in some chromosome regions, it
is very possible that there is a large imprinted gene cluster in the
Sgce-Asb4 region. Therefore, we analyzed the imprinting
status of six other genes in this region (Cas1, Peg10, Neurabin, Pon1,
Pon3, and Pon2) and showed that four genes were imprinted.
Peg10 was paternally expressed, whereas the other three genes showed
preferential maternal expression in the embryonic stage. In relation to these
imprinted genes, we discuss the phenotypes observed in mice with maternal
duplication of proximal chromosome 6 (early embryonic lethality and perinatal
growth retardation) and in human maternal disomy of chromosome 7, which is
associated with the growth retardation phenotype known as Silver-Russell
syndrome (SRS; OMIM No.180860).
 |
RESULTS
|
|---|
Gene Alignment and Analysis of CpG Islands of the
Col1a2-Asb4 Region in the Mouse
Nine genes in mouse proximal chromosome 6 map to a 1-Mb region between 1.2
and 2.2 Mb of the Mus musculus Whole-Genome Shotgun (WGS) supercontig
Mm6_WIFeb01_97 (GenBankaccession no. NW_000272): Col1a2, Cas1, Sgce,
Peg10, Neurabin, Pon1, Pon3, Pon2, and Asb4 (from proximal to
distal, Fig. 1A). This gene
alignment is conserved in the human syntenic 7q21 region (data not shown). In
this report, we characterize the imprinting status of six of these genes
(Cas1, Peg10, Neurabin, Pon1, Pon3, and Pon2), because
Sgce and Asb4 are already known to be imprinted and
Col1a2 is reported to show biallelic expression
(Piras et al. 2000 ;
Mizuno et al. 2002 ). This
region contained four CpG islands (CGIs) corresponding to the promoter regions
of the Cas1, Peg10-Sgce, Neurabin, and Pon2 genes. Bisulfite
sequencing analyses of both day 10 embryo and placenta showed that three
regions were nonmethylated (Fig.
1B), and that of Peg10-Sgce was differentially methylated
(Fig. 2A).

View larger version (53K):
[in this window]
[in a new window]
|
Figure 1 Genomic structure of the Col1a2-Asb4 region in the mouse.
(A) Physical map of the genes identified in a 1-Mb region in the
Mus musculus WGS supercontig Mm6_WIFeb01_97 (GenBank accession no.
NW_000272). The arrows show the direction of each transcription unit, and
imprinted genes are indicated by color: red and pink indicate strong and weak
preferential maternal expression, respectively, and blue indicates complete
paternal expression. Genes showing no expression biases between parental
alleles are shown in black. (B) CpG islands (CGIs) and their DNA
methylation states in the domain. There are four CGIs (length over 300 bp)
shown in green boxes in the Col1a2-Asb4 region, and the three
nonmethylated CGIs determined by bisulfite sequencing of genomic DNA isolated
from (B6 x JF1) F1 embryo and placenta (day 10) are shown.
DNA polymorphisms were used to determine paternal and maternal alleles of
Cas1 CGI and Pon2 CGI, and showed that both alleles were
nonmethylated in this region. No available DNA polymorphisms were found in
Neurabin CGI, but no methylated CpGs were observed in this region
either. Each horizontal line indicates the sequence from a single clone. Each
CpG dinucleotide is represented by an oval. White and black ovals indicate
nonmethylated and methylated CpGs, respectively. Details of the differentially
methylated region of the Peg10-Sgce CGI are shown in
Fig. 2A.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
Figure 2 Peg10 imprinted expression associated with primary DMR.
(A) The genomic structure of Peg10 and bisulfite sequencing
analyses of the Peg10 repeated sequence region. The full-length
Peg10 sequence was determined by 5'-RACE analysis. The white
boxes are untranslated regions and putative open reading frames are shown with
black boxes. Two putative ORFs of Peg10 are shown in gray boxes
below; ORF1 shares 30% amino acid identity with the gag protein, and ORF2
predicted from a -1 frameshift of ORF1 shares 25% identity with the pol
protein of Sushi-ichi retrotransposon, respectively. The translational
frameshifting of ORF1ORF2 is commonly observed in retroviruses and
gypsy-type LTR retrotransposons. The arrows indicate the
5'3' direction of Peg10 and Sgce. The DNA
methylation status of Peg10 repeats in day 10 embryo, eggs, and sperm
are shown. Differential methylation was observed in the day 10 embryo as well
as the day 10 placenta (data not shown). DNA polymorphisms between JF1 and B6
were used to distinguish parental alleles. The entire Peg10-Sgce CpG
island indicated by gray lollipops shows a differentially methylated status
similar to that in the Peg10 repeats (data not shown). (B)
Twelve Peg10 intronic 29-bp repeat sequences. Shaded boxes indicate
homology with the most frequent sequence, GCGCTTCATGCGCTACAAAATACTCATAG (four
times). (C) Northern blot profiles of Peg 10 in mouse adult
tissues. Total RNA from mouse adult brain (lane 1), heart (lane
2), lung (lane 3), liver (lane 4), spleen (lane
5), kidney (lane 6), stomach (lane 7), small
intestine (lane 8), skeletal muscle (lane 9), skin (lane
10), thymus (lane 11), testis (lane 12), uterus
(lane 13), and placenta (lane 14) was analyzed. Ribosomal
RNA detected by ethidium bromide (EtBr) staining was used as a marker. Strong
Peg10 expression was observed only in placenta, and the major
transcript was estimated to be -6.5 kb long. (D) Paternal expression
of Peg10. Paternal expression of Peg10 in day 10 embryo,
placenta, yolk sac, and neonatal brain is demonstrated by direct sequencing of
the RT-PCR products, by comparing the sequence profiles of genomic DNA
containing B6 and JF1 alleles equally.
|
|
We previously reported that human PEG10 was derived from a
Sushi-ichi retrotransposon encoding two ORFs (ORF1 and ORF2) showing
similarity to retroviral Gag and Pol proteins, respectively
(Fig. 2A;
Poulter and Butler 1998 ;
Ono et al. 2001 ).
Peg10 exists in all five mammals that we have examined (human, cat,
dog, olive baboon, and chimpanzee), in the same location as in the mouse
(Fig. 1A; GenBankaccession no.
AC069292
[GenBank]
, AC108197
[GenBank]
, AC113572
[GenBank]
, AC092529
[GenBank]
, and AC094111
[GenBank]
, respectively). Expressed
sequence tags (ESTs) corresponding to Peg10 are also registered for
the cow, rat, mink, and pig (GenBank accession no. AV608102
[GenBank]
, AI599367
[GenBank]
,
MVU00594, and BF191703
[GenBank]
, respectively). Therefore, retrotransposon-derived
Peg10 is highly conserved in mammals.
Genomic Structure and Verification of Imprinting of Mouse
Peg10
We determined the full-length sequence of Peg10, which consists of
6407 bp, by 5'-RACE (Rapid Amplification of cDNA Ends; GenBankaccession
no. AB091827
[GenBank]
). The first exon of Peg10 was identified 6.5 kb upstream
of the second exon and was within 250 bp of the first exon of Sgce,
which is oriented in a head-to-head manner
(Fig. 2A). The genomic
structure of these two genes is also conserved in the human genome (data not
shown). Therefore, it is not an intron-less gene, as we previously reported in
humans (Ono et al. 2001 ).
A CGI overlaps the first two exons of Sgce and Peg10
(Fig. 2A), and there are 12
direct repeats of a 29-bp GC-rich sequence in the Peg10 intron 1,
just downstream of the first Peg10 exon
(Fig. 2B). Bisulfite sequencing
analyses showed that the whole CGI was differentially methylated in paternal
and maternal alleles in both day 10 embryo
(Fig. 2A, lower part) and
placenta (data not shown). Furthermore, it was revealed that differential
methylation was already established in oocytes and sperm. Therefore, this
region is the primary differentially methylated region (DMR), which indicates
that it has an important function in regulating the paternal expression of
both Peg10 and Sgce (see following).
To verify tissue-specific expression, we carried out Northern blot analyses
using a Peg10 3'untranslated region (UTR) fragment as a probe.
As shown in Figure 2C, a high
level of Peg10 expression was observed only in placentas. The major
transcript was estimated to be -6.5 kb, which is consistent with the
full-length cDNA that we identified. Strong expression of human SGCE
and PEG10 in placenta has been reported previously
(McNally et al. 1998 ;
Ono et al. 2001 ).
To verify the imprinting status of Peg10, we examined DNA
polymorphisms in the Peg10 3'UTR between JF1 and C57BL/6 (the G
and A residues indicated by arrows in Fig.
2D, respectively) by direct sequencing. In day 10 F1
embryos of the crosses (B6 x JF1 and JF1 x B6), only paternal G
residues were detected in the placentas, yolksacs, and neonatal brains in the
former, and only paternal A residues were detected in the latter samples.
Therefore, paternal expression of Peg10 was confirmed in mice, as
occurs with human PEG10.
Genes Showing Preferential Maternal Expression
To test the imprinting status of the remaining five genes (Cas1,
Neurabin, Pon1, Pon3, and Pon2), we examined DNA polymorphisms
between JF1 and C57BL/6. Allele-specific expression analyses were carried out
using a restriction fragment length polymorphism (RFLP) method combined with
the Hot-stop RT-PCR method (Uejima et al.
2000 ). To exclude the possible misinterpretation of imprinting
status because of the existence of overlapping RNAs, we confirmed that no
other cDNA bands of different sizes or genomic DNA bands of the same size were
detected in RT-PCR experiments for each gene, when the two primers were
located in different exons. In addition, the amplified bands were directly
sequenced to confirm that they were derived from the genes in question.
Cas1, which encodes a putative glycosyltransferase, is a conserved
gene found in humans, Drosophila, plants, and bacteria
(Janbon et al. 2001 ). In the
mouse, RT-PCR experiments with RNA from a range of adult tissues showed that
Cas1 was expressed ubiquitously
(Fig. 3A). In the RFLP
analysis, Cas1 showed complete or equal biallelic expression in
neonatal brain. It was also biallelically expressed in day 10 and 13 embryo,
placenta, and yolksac samples, but there seemed to be weakmaternal biases,
especially in extraembryonic tissues (data not shown). Therefore, an RFLP
analysis combined with Hot-stop PCR was performed to quantify the expression
of each allele precisely. The levels of JF1 and B6 expression went up and down
reciprocally in two reciprocal F1 samples
(Fig. 3B), indicating its
imprinting. However, the expression ratios of maternal/paternal alleles (M/P
values) in these samples were small (no more than twofold) and were not
conclusive.

View larger version (41K):
[in this window]
[in a new window]
|
Figure 3 Characterization of Cas1 and Neurabin. (A)
Expression profiles of Cas1. The RT-PCR products (30 cycles for
Cas1 and 25 cycles for the control Gapdh) using total RNA
from a range of adult tissues (brain, skeletal muscle, spleen, kidney, liver,
and lung) are shown. (B) Cas1 expression in the embryonic
stage. In the DdeI RFLP experiment combined with Hot-stop PCR using a
radioisotope-labeled primer, the B6 and JF1 alleles yielded 102- and 670-bp
fragments, respectively. Three experiments were carried out in the same
samples and the average ratios between the B6 and JF1 alleles, and also
between maternal and paternal alleles (M/P values), are shown below. Similar
results were obtained in the tissues from different individuals (data not
shown). (C) Northern blot profiles of Neurabin in mouse
adult tissues. Strong expression is observed in the brain sample, whereas weak
ubiquitous expression is observed in all other tissues. (D) Maternal
expression of Neurabin. In the AciI RFLP analysis with
Hot-stop PCR, the B6 and JF1 alleles yielded 240- and 100-bp fragments,
respectively. Preferential maternal expression was observed in placenta (day
10) and yolk sac (day 10 and 13) samples. The gray boxes indicate clear
maternal biases in reciprocal crosses.
|
|
Neurabin was first isolated as an actin filament (F-actin)-binding protein
in the rat. It regulates synapse formation in vitro and is specifically
expressed in neural tissues (Nakanishi et
al. 1997 ). As shown in Figure
3C, Neurabin was strongly expressed in the brain. Allelic
expression analysis using RFLP with Hot-stop PCR showed biallelic expression
of Neurabin in the neonatal brain, and preferential maternal
expression was observed in placenta (day 10) and yolksac (day 10 and 13)
samples (Fig. 3D). In these
tissues, the ratio of expression of a 240-bp band derived from the B6 allele
to that of a 100-bp band from the JF1 allele was constantly higher in (B6
x JF1) F1 samples and lower in reciprocal (JF1 x B6)
F1 samples. The M/P values of placentas were 3.5 and 2.6 (day 10)
in (B6 x JF1) F1 and (JF1 x B6) F1,
respectively, and these values for yolksac samples were 2.2 and 4.9 (day 10)
and 2.0 and 4.6 (day 13). Because it is apparent that placenta samples from
day 13 contain significant amounts of maternal tissue, we did not analyze
these samples. We also cannot exclude the possibility of maternal tissue
contamination from placenta samples completely, even when isolated from day 10
conceptus, whereas yolksac samples can be recovered free from maternal
contamination. Therefore, we conclude that Neurabin is also a
maternally expressed imprinted gene at the embryonic stage, especially in
extraembryonic tissues.
The three Pon genes are located adjacent to each other on mouse
chromosome 6 and human chromosome 7 (Fig.
1A; Primo-Parmo et al.
1996 ). Human PON1, PON2, and PON3 share 65% similarity at the
amino acid level. PON1 is an enzyme associated with high-density lipoprotein
(HDL) that is believed to protect against the early events of atherogenesis
via its ability to hydrolyze oxidized phospholipids. It is also involved in
the detoxification of organophosphate insecticides, such as parathion and
chlorpyrifos. In contrast, PON2 and PON3 lack paraoxonase activity, although
they have similar antioxidant properties. PON3 is also found in HDL, whereas
PON2 is not associated with HDL (Davies et
al. 1996 ; Shih et al.
1998 ; Draganov et al.
2000 ; Ng et al.
2001 ).
As shown in Figure 4A,
Pon1 expression was detected mainly in liver and lung. Therefore, we
tested the imprinting status of Pon1 in liver and lung from neonates.
As shown in Figure 4B, the same
biallelic expression pattern of Pon1 was observed between reciprocal
F1 crosses, although it is apparent that the expression of the JF1
allele was constantly higher than that of the B6 allele in both tissues. It
has been reported that DNA polymorphisms in human promoter regions affect the
levels of IL-4 and TNF- expression
(Song et al. 1996 ;
Wilson et al. 1997 ).
Therefore, it is highly possible that genes showing strain-specific (or
strain-biased) expression exist in the mouse. In this experiment, apparent
allele-biased expression was also observed in Pon2 and Pon3
(see following). To distinguish imprinted parental allele-specific expression
from strain-specific expression, it is very important to analyze the
imprinting status in the F1 of both crosses. It was difficult to
obtain reliable results from embryos, placentas, and yolksacs because of low
expression of Pon1 in these tissues (data not shown). Mouse
Pon2 is ubiquitously expressed
(Fig. 4A) and biallelic
expression was observed in neonatal brain
(Fig. 4C, right-hand lanes) and
other neonatal tissues (skeletal muscle, spleen, kidney, liver, and lung; data
not shown). However, significant maternally biased expression was observed in
day 10 placenta (3.5 and 4.0) and to a lesser degree in day 13 yolk sac
samples (1.9 and 2.0) in (B6 x JF1) F1 and (JF1 x B6)
F1, respectively (Fig.
4C). Therefore, Pon2 is imprinted, at least, in these
restricted tissues at the embryonic stages.

View larger version (51K):
[in this window]
[in a new window]
|
Figure 4 Characterization of Pon1, Pon2, and Pon3. (A)
Expression profiles of Pon1, Pon2, and Pon3. RT-PCR products
(30 cycles for Pon1, Pon2, and Pon3, and 25 cycles for
Gapdh) from the same adult tissues used in
Fig. 3A are shown.
Pon2 was expressed ubiquitously, whereas Pon1 and
Pon3 expression were observed mainly in liver and lung. (B)
Biallelic expression of Pon1. In the MspI RFLP experiment
with Hot-stop PCR, the B6 and JF1 alleles yielded 600- and 150-bp fragments,
respectively. The biallelic expression patterns were unchanged between
reciprocal crosses, although JF1 alleles were always expressed more strongly
than B6 alleles. (C) Maternal expression of Pon2. In the
HaeIII RFLP experiment with Hot-stop PCR, the B6 and JF1 alleles
yielded 187-bp and 389-bp fragments, respectively. Preferential maternal
expression of Pon2 was observed in placenta and to a lesser degree in
day 13 yolk sac. (D) Maternal expression of Pon3. In the
PleI RFLP experiment with Hot-stop PCR, the B6 and JF1 alleles
yielded 534-bp and 727-bp fragments, respectively. Maternal biases of both the
B6 and JF1 alleles were observed in day 10 placenta and day 13 yolk sac and
also observed in day 10 embryo to a lesser degree. Note that the B6 allele was
expressed more strongly than the JF1 allele in all cases.
|
|
As shown in Figure 4A, mouse
Pon3 is expressed mainly in liver and lung in the adult. There was no
evidence of its imprinting in neonatal liver and lung
(Fig. 4D, right-hand lanes).
However, Pon3 showed maternally biased expression in day 10 placenta
and day 13 yolksac samples, because the B6 (534 bp) and JF1 (727 bp) alleles
went up and down reciprocally in these tissues of two different F1s
(Fig. 4D). Similar maternal
biases were also observed in day 10 embryo to a lesser degree. It was also
evident that the expression of B6 alleles in embryo, placenta, and yolksac was
much higher than that of JF1 alleles in both reciprocal F1s.
Therefore, M/P values are not a good indicator of imprinting in this case.
 |
DISCUSSION
|
|---|
In this study, we demonstrated that at least two paternally expressed genes
and four maternally expressed genes are located in a 1-Mb region between
Col1a2 and Asb4 in the mouse proximal chromosome 6 and form
a large cluster of imprinted genes. Of these, Sgce and Peg10
show paternal expression in an all-or-none fashion, and Asb4 shows
mainly maternal expression with a lesser paternal contribution
(Piras et al. 2000 ;
Mizuno et al. 2002 ). One
characteristic of this cluster is that three genes (Neurabin, Pon2,
and Pon3) show preferential maternal expression in the embryonic
stage. They show biallelic expression in neonatal tissues, but their
expression in extra-embryonic tissues appears maternally biased. Although most
imprinted genes identified so far show clear all-or-none monoallelic
expression patterns, some imprinted genes showing weak parental preferences
were recently reported, including Tnfrh1 on mouse distal chromosome 7
and Dio3 on mouse distal chromosome 12
(Clark et al. 2002 ;
Tsai et al. 2002 ). The former
shows a weakmaternal bias in several organs and the latter shows preferential
paternal expression in embryos and placentas to differing degrees. It is
rational to expect that genes showing differential expression of paternal and
maternal alleles that are always associated with the same parental biases be
classified as imprinted genes.
What is the mechanism of this preferential expression? There are three
possibilities: (1) the existence of overlapping transcripts from other gene(s)
showing paternal or biallelic expression; (2) the existence of two promoters,
one for maternal expression and the other for biallelic expression; and (3)
the relaxation of genomic imprinting: the change from an imprinted state to a
nonimprinted state occurs in certain situations.
The first possibility, overlapping RNA, such as readthrough products of
Peg10, can be excluded, because no other cDNA bands of different
sizes or genomic DNA bands of the same size were detected in RT-PCR
experiments for Pon1 and Pon2, when the two primers were
located in different exons. The amplified bands were directly sequenced to
confirm that they were derived from the genes in question, as mentioned.
Moreover, as far as the expression profile of Peg10 is concerned,
this hypothesis is unlikely, because Peg10 is strongly expressed only
in placentas, where the maternal preferential expression of these genes was
observed; the genes showed completely biallelic expression in neonatal
tissues, where Peg10 expression is very low.
The second possibility is more likely, because several EST clones
possessing different transcription start sites for Neurabin have been
registered in GenBank(accession no. AW048064
[GenBank]
, BB617696
[GenBank]
, and BB639924
[GenBank]
). There
are also several examples in which different promoters show different
expression profiles depending on tissue and developmental stage. These include
Igf2 and human PEG1/MEST (paternal and biallelic), Gnas,
Nesp, and GnasXL (paternal, maternal, and biallelic) and mouse
Meg1/Grb10 (maternal and paternal) and human GRB10
(biallelic and paternal; Vu and Hoffman
1994 ; Peters et al.
1999 ; Kosaki et al.
2000 ; Li et al.,
2000 ; Kobayashi et al.,
2001 ; Hikichi et al.
2003 ). In such cases, intermediate types of expression should be
observed where two different transcripts overlap. Further analyses to identify
the precise promoters of these genes will be necessary to test this
possibility.
It is also worth considering the third possibility, the relaxation of
imprinting, because there is evidence for a change in the expression of
imprinted genes associated with a change in DNA methylation in DMR regions in
some diseases and cancers as a result of mutation or deletions. However, we do
not know of a mechanism that relaxes imprinting functions in normal
development without changes in DNA sequences.
In conclusion, the maternal bias in expression should be reflected by some
imprinting-related mechanism, overlapping transcripts from different promoters
showing different parental expression profiles, or the relaxation of
imprinting.
There are two conserved imprinted regions in the mouse proximal chromosome
6 and the human syntenic region of the long arm of chromosome 7. In the mouse,
the Peg1/Mest region is responsible for perinatal growth retardation,
and the region examined in this workis responsible for early embryonic
lethality when maternal duplication occurs. However, human maternal disomy of
the chromosome 7 containing both imprinted regions is associated with the
perinatal growth retardation known as Silver-Russell syndrome, but there is no
evidence of early embryonic lethality
(Preece et al. 1997 ).
Therefore, two questions arise concerning the latter imprinted region: what
gene(s) is responsible for early embryonic lethality in the mouse and why is
no severe lethal phenotype observed in humans?
One simple possibility is the existence of a mouse-specific imprinted
gene(s) that causes early embryonic lethality. We have confirmed that both
human PEG10 and mouse Peg10 are paternally expressed in an
all-or-none manner. It has been reported that a mutation in human
SGCE on chromosome 7q21 causes myoclonic dystonia (OMIM no.159900),
which is characterized by bilateral, alcohol-sensitive myoclonic jerks
involving mainly the arms and axial muscles
(Zimprich et al. 2001 ). The
family trees of patients show paternal inheritance of this disease, indicating
that human SGCE is also a paternally expressed gene. However, it is
not known whether it shows completely monoallelic expression, as with mouse
Sgce, or paternal expression with a maternal contribution. The
imprinting status of the other four human homologs corresponding to the mouse
maternally expressed genes, Neurabin, Pon2, Pon3, and Asb4,
is not known. Therefore, analyses of these human homologs are required to
elucidate phenotype differences between the human and mouse. In this study, we
analyzed genes in a 1-Mb region near Sgce and Asb4. It is
also probable that there are other imprinted genes responsible for the mouse
lethal phenotype downstream from Asb4.
Another explanation for the humanmouse phenotype discrepancy is the
difference in the mechanisms producing human uniparental disomies and mouse
uniparental duplications. It has been reported that some human chromosomal
disomies arise from trisomies, because congenital chromosome mosaicism showing
trisomy in placentas containing both paternal and maternal alleles is
sometimes observed in human uniparental disomy patients. In contrast, mice
with maternal duplication have been constructed by mating mice with
Robertsonian translocations or reciprocal translocations at the same locus
(see
http://www.mgu.har.mrc.ac.uk/imprinting/imprinting.html ).
Consequently, all the tissues in the embryos and placentas possess two
maternal alleles for the duplicated regions. Therefore, it is possible that
the mouse early embryonic phenotype results from a placental abnormality,
which is not apparent in the human case. In this case, Sgce and
Peg10 are most likely involved, because they show complete paternal
expression and are strongly expressed in placentas. Gene targeting approaches
to these genes are necessary to test this possibility.
In this report, we identified a primary DMR in the region where the first
exons of Sgce and Peg10 overlap. Twelve repeat sequences of
a 29-bp fragment are located within a CGI just downstream from the
Peg10 first exon. It would be very interesting to determine whether
this DMR regulates only the two paternally expressed genes or all the genes in
the cluster, including the maternally expressed genes, because there are no
apparent DMRs in this region. A gene-targeting study of the DMR will be very
important for elucidating the mechanism regulating this imprinted region in
mouse proximal chromosome 6.
 |
METHODS
|
|---|
Identification of Genes and CGIs From a 1-Mb Region Between
Col1a2 and Asb4
The genomic sequence in the 1-Mb region between Mb 1.2 and 2.2 of Mus
musculus WGS supercontig Mm6_WIFeb01_97 (GenBankaccession no. NW_000272)
containing Sgce and Asb4 was repeat-masked using Repeat
Masker, and then used in a BLASTN search of db ESTs to identify transcripts.
Five of the identified EST clusters were identical to mouse Col1a2
(GenBankaccession no. NM_007743
[GenBank]
), Sgce (NM_011360
[GenBank]
), Pon1
(NM_011134
[GenBank]
), Pon2 (NM_008896
[GenBank]
), Pon3 (NM_008897), and
Asb4 (NM_023048
[GenBank]
), and the rest were orthologs of human Cas1
(NM_022900
[GenBank]
), PEG10 (NM_015068
[GenBank]
), and rat Neurabin
(NM_053473
[GenBank]
). The mouse gene sequences (registered as Peg10: AB091827
[GenBank]
,
Neurabin: AB091828
[GenBank]
, and Cas1: AB091829
[GenBank]
) were confirmed using
RT-PCR and nucleotide sequencing. To identify CGIs, we ran the program Cpgplot
(http://www.ebi.ac.uk/emboss/cpgplot/ )
with the following parameters: Observed/Expected ratio > 0.60, Percent C +
Percent G > 50.00, Length > 300. Four CGIs were identified:
Cas1 CGI (1304815bp-1305668bp; NW_000272), Peg10-Sgce CGI
(1453104bp-1453415bp; NW_000272), Neurabin CGI (1609519bp-1610544bp;
NW_000272), and Pon2 CGI (2009459bp-2010036bp; NW_000272)
corresponding to the promoter regions of these genes.
RT-PCR and 5'-RACE
Genomic DNA and total RNA were prepared from several tissues from the
F1 of (B6 x JF1), (JF1 x B6), and (B6 x C3H)
mice, using ISOGEN (Nippon Gene), as described previously
(Kaneko-Ishino et al. 1995 ).
cDNA was synthesized from 1 µg of total RNA using Superscript II reverse
transcriptase (Life Technologies) with an oligodT primer. Gene expression
profiles were deduced by agarose gel electrophoresis of RT-PCR products with
ethidium bromide (EtBr) staining. The primers used for the expression profiles
were the same as those described in the next section. A SMART RACE cDNA
Amplification Kit (Clontech) was used for 5'-RACE, following the
manufacturer's protocol. RNA was prepared from B6 day 16 embryos, and the
gene-specific primer used was GSP: 5'-GTGAGAGGGGCTTCACTCCCCTG-3'.
The amplified DNA fragments were purified and sequenced directly.
Allelic Analysis of Gene Expression Combined With Hot-Stop PCR
DNA polymorphisms in six genes between JF1 and C57BL/6 were detected in
restriction fragment length polymorphism (RFLP) and single site polymorphism
(SSP) analyses. For RT-PCR, 10 ng of cDNA in a 100-µL reaction mixture
containing 1x ExTaq buffer (TaKaRa), 2.5 mM dNTP mixture, primers, and
2.5 U of ExTaq (TaKaRa) was subjected to 3035 PCR cycles. In the case
of Pon3, we performed nested PCR and added 10 PCR cycles in the
second amplification. PCR was carried out on a Perkin Elmer GeneAmp PCR system
2400 under the following cycle conditions: 96°C for 15 sec, 65°C for
30 sec, and 72°C for 30 sec. The final cycle of PCR was performed in the
presence of a primer labeled with [ -32P] ATP. The PCR
product was digested with the appropriate restriction endonuclease and
electrophoresed on a 10% polyacrylamide gel. The intensity of the PCR products
was measured with a BAS2000 Bioimaging Analyzer (Fuji Film). Experiments were
carried out three times and average ratios were shown. Errors in observed
values were within 5% in all cases except J x B yolksac (day 13) of
Cas1. The following primers were used for DNA amplification:
Cas1, 5'-AGCAGAGTGTAACGAACTCCAC-3' and
5'-CACAGTGGACGGGTGAATGTGC-3' *; Neurabin,
5'-ACTCTCCTGCCGAGGCTG-3' and
5'-CAGTTTCAGGGGCTCTCACT-3' *; Peg10,
5'-GGGTAGATAATCATAAGTATTTTGGGC-3' and
5'-CAACATTCTAAACTTTATTCCAGCAAC-3'; Pon1,
5'-ACAAGAACCATCGGTCTTCC-3' * and
5'-CCTTCTGCTACCACCTGGAC-3'; Pon2,
5'-ACGAGCTCCTTCCAAGTGTG-3' and
5'-ACCTCTGATGCAGGAGGATG-3' *; Pon3 (the first
amplificaton), 5'-TCAGAAGTACTACGCATCCAGG-3'
and5'-CATGGCTGAAGGTAACTGTCC-3'; Pon3 (the second
amplification), 5'-GAACAACGGCTCTGTGCTTC-3' * and
5'-ATGCACCAAGCTAGCTGATG-3'. Asterisks indicate labeled primers
with [ -32P] ATP used in the last PCR cycles.
For RFLP analysis of Cas1, Neurabin, Pon1, Pon2, and
Pon3, the PCR products were digested with DdeI,
AciI, MspI, HaeIII, and PleI. For SSP
analysis of Peg10, the PCR product was sequenced on an ABI 3100
sequencer using Big-Dye terminator chemistry (Applied Biosystems).
Methylation Analyses of Embryos, Placentas, Eggs, and Sperm
Genomic DNA and RNA were isolated from both day 10 embryos and placentas,
as well as eggs and sperm, using ISOGEN, as described in the RT-PCR section.
Purified genomic DNA was treated with a sodium bisulfite solution, as
described previously (Raizis et al.
1995 ). During this process, cytosine was converted to uracil,
except methylated cytosine. The sodium bisulfite-treated DNA was amplified
with following the primers: Peg10-Sgce CGI,
5'-GTAAAGTGATTGGTTTTGTATTTTTAAGTG-3' and
5'-TTAATTACTCTCCTACAACTTTCCAAATT-3'; Cas1 CGI,
5'-GTTTAGGTAGTTGTTAGTTTATTTGGGTATAG-3' and
5'-CCTCCCTAATAACCTCCTACCTTAATAAC-3'; Neurabin CGI,
5'-GGTGTTTTTTGGTATTAGGTTAGATTG-3' and
5'-ATAAACACCCTCCCCTCTCC-3'; Pon2 CGI,
5'-AGTGTTTAGGTTTTGGTGGAAGTG-3' and
5'-CCCAAACTTAACTAAATTAAAAAAACTCC-3'.
The DNA fragments were amplified using ExTaq (TaKaRa) for 3540
cycles under the following cycle conditions: 96°C for 15 sec, 60°C for
30 sec, and 72°C for 1 min. The amplified fragments were cloned into
plasmids and sequenced. DNA polymorphisms in Peg10 promoter region
(T/A; B6/JF1;1453020 bp; NW_000272) and DNA polymorphisms in Cas1
promoter region (A/G; B6/JF1;1304769 bp; NW_000272) and in Pon2
promoter region (T/G; B6/JF1; 2009669 bp; NW_000272) were used to determine
paternal and maternal alleles of Cas1 CGI and Pon2 CGI,
respectively.
Northern Blot Analysis
To analyze Peg10 and Neurabin expression, we used
membranes of numerous adult tissues in Northern blot (Seegene, Korea)
experiments. The 3' part of Peg10 was amplified with primers
5'-GGGTAGATAATCATAAGTATTTTGGGC-3' and
5'-CAACATTCTAAACTTTATTCCAGCAAC-3' and Neurabin was
amplified with primers 5'-ACTCTCCTGCCGAGGCTG-3' and
5'-CAGTTTCAGGGGCTCTCACT-3', and used as a DNA probe. Hybridization
was performed at 42°C in Ultrasensitive Hybridization Buffer (Ambion) for
18 h. The membrane was then washed with a solution containing SSC and 0.1% SDS
at 42°C to a final stringency of 0.1 x SSC.
 |
Acknowledgements
|
|---|
This workwas supported by grants from CREST, the research program of the
Japan Science and Technology Cooperation (JST), Asahi Glass Foundation, Uehara
Memorial Life Science Foundation and the Ministry of Health, Labour for Child
Health and Development (14-C) to F.I.
The publication costs of this article were defrayed in part by payment of
page charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 USC Section 1734 solely to
indicate this fact.
 |
Footnotes
|
|---|
Article and publication are at
http://www.genome.org/cgi/doi/10.1101/gr.906803.
6 Corresponding author. E-MAIL
fishino{at}bio.titech.ac.jp;
FAX 81-45-924-5814. 
[Supplemental material is available online at www.genome.org. The sequence
data from this study have been submitted to DDBJ under accession nos.
AB091827
[GenBank]
AB091829.]
 |
REFERENCES
|
|---|
Beechey, C.V. 2000. Peg1/Mest locates distal
to the currently defined imprinting region on mouse proximal chromosome 6 and
identifies a new imprinting region affecting growth. Cytogenet.
Cell Genet. 90:
309-314.[CrossRef][Medline]
Clark, L., Wei, M., Cattoretti, G., Mendelsohn, C., and Tycko, B.
2002. The Tnfrh1 (Tnfrsf23) gene is weakly
imprinted in several organs and expressed at the trophoblast-decidua
interface. BMC Genet. 3:
11[CrossRef][Medline]
Davies, H.G., Richter, R.J., Keifer, M., Broomfield, C.A., Sowalla,
J., and Furlong, C.E. 1996. The effect of the human serum
paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Nat. Genet. 14:
334-336.[CrossRef][Medline]
Draganov, D.I., Stetson, P.L., Watson, C.E., Billecke, S.S., and La
Du, B.N. 2000. Rabbit serum paraoxonase 3 (PON3) is a
high-density lipoprotein-associated lactonase and protects low-density
lipoprotein against oxidation. J. Biol. Chem.
275:
33435-33442.[Abstract/Free Full Text]
Hikichi, T., Kohda, T., Kaneko-Ishino, T., and Ishino, F.
2003. Imprinting regulation of the murine
Meg1/Grb10 and human GRB10 genes; roles of
brain-specific promoters and mouse-specific CTCF-binding sites.
Nucleic. Acids Res. 31:
1398-1406.[Abstract/Free Full Text]
Janbon, G., Himmelreich, U., Moyrand, F., Improvisi, L., and
Dromer, F. 2001. Cas1p is a membrane protein necessary for the
O-acetylation of the Cryptococcus neoformans capsular polysaccharide.
Mol. Microbiol. 42:
453-467.[CrossRef][Medline]
Kaneko-Ishino, T., Kuroiwa, Y., Miyoshi, N., Kohda, T., Suzuki, R.,
Yokoyama, M., Viville, S., Barton, S.C., Ishino, F., and Surani, M.A.
1995. Peg1/Mest imprinted gene on chromosome 6
identified by cDNA subtraction hybridization. Nat.
Genet. 11:
52-59.[CrossRef][Medline]
Kobayashi, S., Vemura, T., Kohda, T., Nagai, T., Chinen, Y.,
Naritomi, K., Kinoshita, E.I., Ohashi, H., Imaizumi, K., Tsukahara, M., et al.
2001. No evidence of PEG1/MEST gene mutations in Silver-Russell
syndrome patients. Am. J. Med. Genet.
104:
225-231.[CrossRef][Medline]
Kosaki, K., Kosaki, R., Craigen, W.J., and Matsuo, N.
2000. Isoform-specific imprinting of the human PEG1/MEST
gene. Am. J. Hum. Genet.
66:
309-312.[CrossRef][Medline]
Lefebvre, L., Viville, S., Barton, S.C., Ishino, F., Keverne, E.B.,
and Surani, M.A. 1998. Abnormal maternal behaviour and growth
retardation associated with loss of the imprinted gene Mest. Nat.
Genet. 20:
163-169.[CrossRef][Medline]
Li, T., Vu, T.H., Zeng, Z.L., Nguyen, B.T., Hayward, B.E.,
Bonthron, D.T., Hu, J.F., and Hoffman, A.R. 2000. Tissue-specific
expression of antisense and sense transcripts at the imprinted Gnas
locus. Genomics 69:
295-304.[CrossRef][Medline]
McNally, E.M., Ly, C.T., and Kunkel, L.M. 1998. Human
-sarcoglycan is highly related to -sarcoglycan
(adhalin), the limb girdle muscular dystrophy 2D gene.
FEBS Lett. 422:
27-32.[CrossRef][Medline]
Mizuno, Y., Sotomaru, Y., Katsuzawa, Y., Kono, T., Meguro, M.,
Oshimura, M., Kawai, J., Tomaru, Y., Kiyosawa, H., Nikaido, I., et al.
2002. Asb4, Ata3, and Dcn are novel imprinted
genes identified by high-throughput screening using RIKEN cDNA microarray.
Biochem. Biophys. Res. Commun.
290:
1499-1505.[CrossRef][Medline]
Nakanishi, H., Obaishi, H., Satoh, A., Wada, M., Mandai, K., Satoh,
K., Nishioka, H., Matsuura, Y., Mizoguchi, A., and Takai, Y.
1997. Neurabin: A novel neural tissue-specific actin
filament-binding protein involved in neurite formation. J. Cell
Biol. 139:
951-961.[Abstract/Free Full Text]
Ng, C.J., Wadleigh, D.J., Gangopadhyay, A., Hama, S., Grijalva,
V.R., Navab, M., Fogelman, A.M., and Reddy, S.T. 2001.
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant
properties and is capable of preventing cell-mediated oxidative modification
of low-density lipoprotein. J. Biol. Chem.
276:
44444-44449.[Abstract/Free Full Text]
Ono, R., Kobayashi, S., Wagatsuma, H., Aisaka, K., Kohda, T.,
Kaneko-Ishino, T., and Ishino, F. 2001. A retrotransposon-derived
gene, PEG10, is a novel imprinted gene located on human chromosome
7q21. Genomics 73:
232-237.[CrossRef][Medline]
Peters, J., Wroe, S.F., Wells, C.A., Miller, H.J., Bodle, D.,
Beechey, C.V., Williamson, C.M., and Kelsey, G. 1999. A cluster
of oppositely imprinted transcripts at the Gnas locus in the distal
imprinting region of mouse chromosome 2. Proc. Natl. Acad.
Sci. 96:
3830-3835.[Abstract/Free Full Text]
Piras, G., El Kharroubi, A., Kozlov, S., Escalante-Alcalde, D.,
Hernandez, L., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., and Stewart, C.L.
2000. Zac1 (Lot1), a potential tumor suppressor
gene, and the gene for -sarcoglycan are maternally imprinted
genes: Identification by a subtractive screen of novel uniparental fibroblast
lines. Mol. Cell. Biol.
20:
3308-3315.[Abstract/Free Full Text]
Poulter, R. and Butler, M. 1998. A retrotransposon
family from the pufferfish (fugu) Fugu rubripes. Gene
215:
241-249.[CrossRef][Medline]
Preece, M.A., Price, S.M., Davies, V., Clough, L., Stanier, P.,
Trembath, R.C., and Moore, G.E. 1997. Maternal uniparental disomy
7 in Silver-Russell syndrome. J. Med. Genet.
34: 6-9.[Abstract]
Primo-Parmo, S.L., Sorenson, R.C., Teiber, J., and La Du, B.N.
1996. The human serum paraoxonase/arylesterase gene
(PON1) is one member of a multigene family.
Genomics 33:
498-507.[CrossRef][Medline]
Raizis, A.M., Schmitt, F. and Jost, J.P. 1995. A
bisulfite method of 5-methylcytosine mapping that minimizes template
degradation. Anal. Biochem.
226:
161-166.[CrossRef][Medline]
Shih, D.M., Gu, L., Xia, Y.R., Navab, M., Li, W.F., Hama, S.,
Castellani, L.W., Furlong, C.E., Costa, L.G., Fogelman, A.M., et al.
1998. Mice lacking serum paraoxonase are susceptible to
organophosphate toxicity and atherosclerosis. Nature
394:
284-287.[CrossRef][Medline]
Song, Z., Casolaro, V., Chen, R., Georas, S.N., Monos, D., and Ono,
S.J. 1996. Polymorphic nucleotides within the human IL-4
promoter that mediate overexpression of the gene. J.
Immunol. 156:
424-429.[Abstract]
Tsai, C., Lin, S., Ito, M., Takagi, N., Takada, S., and
Ferguson-Smith, A. 2002. Genomic imprinting contributes to
thyroid hormone metabolism in the mouse embryo. Curr.
Biol. 12:
1221.[CrossRef][Medline]
Uejima, H., Lee, M.P., Cui, H., and Feinberg, A.P.
2000. Hot-stop PCR: A simple and general assay for linear
quantitation of allele ratios. Nat. Genet.
25:
375-476.[CrossRef][Medline]
Vu, T.H. and Hoffman, A.R. 1994. Promoter-specific
imprinting of the human insulin-like growthfactor-II gene.
Nature 371:
714-717.[CrossRef][Medline]
Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O., and
Duff, G.W. 1997. Effects of a polymorphism in the human tumor
necrosis factor promoter on transcriptional activation.
Proc. Natl. Acad. Sci.
94:
3195-3199.[Abstract/Free Full Text]
Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D.,
Bertram, M., Scheidtmann, K., Kern, P., Winkelmann, J., Muller-Myhsok, B., et
al. 2001. Mutations in the gene encoding
-sarcoglycan cause myoclonus-dystonia syndrome. Nat.
Genet. 29:
66-69.[CrossRef][Medline]
 |
WEB SITE REFERENCES
|
|---|
http://www.ebi.ac.uk/emboss/cpgplot/;
CpG Island finder and plotting tool.
http://www.mgu.har.mrc.ac.uk/imprinting/imprinting.html;
Mouse imprinting maps and data.
Received October 13, 2002;
accepted in revised format May 12, 2003.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Zaitoun and H. Khatib
Comparative genomic imprinting and expression analysis of six cattle genes
J Anim Sci,
January 1, 2008;
86(1):
25 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Clark, M. Janicke, U. Gottesbuhren, T. Kleffmann, M. Legge, E. S. Poole, and W. P. Tate
Mammalian Gene PEG10 Expresses Two Reading Frames by High Efficiency 1 Frameshifting in Embryonic-associated Tissues
J. Biol. Chem.,
December 28, 2007;
282(52):
37359 - 37369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Wood, D. Bourc'his, T. H. Bestor, and R. J. Oakey
Allele-specific demethylation at an imprinted mammalian promoter
Nucleic Acids Res.,
November 29, 2007;
35(20):
7031 - 7039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, H. Yuling, J. Yanping, T. Xinti, Y. Yaofang, Y. Feng, X. Ruijin, W. Li, C. Lang, L. Jingyi, et al.
CCL19 and CXCL13 Synergistically Regulate Interaction between B Cell Acute Lymphocytic Leukemia CD23+CD5+ B Cells and CD8+ T Cells
J. Immunol.,
September 1, 2007;
179(5):
2880 - 2888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. W. Zhang, H. C. Cheng, C. D. Jiang, C. Y. Deng, Y. Z. Xiong, F. E. Li, and M. G. Lei
Imprinted status of pleomorphic adenoma gene-like I and paternal expression gene 10 genes in pigs
J Anim Sci,
April 1, 2007;
85(4):
886 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chunsong, H. Yuling, W. Li, X. Jie, Z. Gang, Z. Qiuping, G. Qingping, Z. Kejian, Q. Li, A. E. Chang, et al.
CXC Chemokine Ligand 13 and CC Chemokine Ligand 19 Cooperatively Render Resistance to Apoptosis in B Cell Lineage Acute and Chronic Lymphocytic Leukemia CD23+CD5+ B Cells
J. Immunol.,
November 15, 2006;
177(10):
6713 - 6722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Schanen
Epigenetics of autism spectrum disorders
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R138 - R150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-M. Li, A. A. Margolin, M. Salas, L. Memeo, M. Mansukhani, H. Hibshoosh, M. Szabolcs, A. Klinakis, and B. Tycko
PEG10 Is a c-MYC Target Gene in Cancer Cells
Cancer Res.,
January 15, 2006;
66(2):
665 - 672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Nakabayashi, S Makino, S Minagawa, A C Smith, J S Bamforth, P Stanier, M Preece, L Parker-Katiraee, T Paton, M Oshimura, et al.
Genomic imprinting of PPP1R9A encoding neurabin I in skeletal muscle and extra-embryonic tissues
J. Med. Genet.,
August 1, 2004;
41(8):
601 - 608.
[Full Text]
[PDF]
|
 |
|
|